a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLFZX | 8.34 | N/A | N/A |
Harding Loevner Frontier Emerg MktsInstZ | |||
HESGX | 45.96 | -0.08 | -0.17% |
Horizon Defensive Core Investor | |||
NEJCX | 7.22 | -0.03 | -0.41% |
Natixis Vaughan Nelson Small Cap Value C | |||
EEMPX | 8.05 | -0.08 | -0.98% |
MFS Emerging Markets Equity Research A | |||
FCVCX | 17.17 | -0.20 | -1.15% |
Fidelity Advisor Small Cap Value C |
A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To LCTX | 1D Price Change % | ||
---|---|---|---|---|
LCTX | 100% | +0.51% | ||
MDGL - LCTX | 43% Loosely correlated | -0.12% | ||
GBIO - LCTX | 38% Loosely correlated | -5.96% | ||
XNCR - LCTX | 36% Loosely correlated | +1.84% | ||
KPTI - LCTX | 35% Loosely correlated | -2.60% | ||
MGTX - LCTX | 35% Loosely correlated | -6.20% | ||
More |